The rising number of companion animals and increasing expenditure on veterinary services are creating favorable conditions for market growth. Pet owners across North America are increasingly seeking convenient products to protect animals against common parasites, while veterinary professionals continue to recommend regular parasite-control programs.

Market Overview

The Veterinary Parasiticides market was valued at US$ 11.35 billion in 2025 and is expected to reach US$ 21.52 billion by 2034; it is estimated to record a CAGR of 7.37% during 2026-2034.The increasing prevalence of parasitic infections, growing pet ownership, expansion of livestock production, and rising expenditure on animal healthcare are supporting market growth. Continued development of broad-spectrum and convenient parasite-control products is also contributing to the adoption of veterinary parasiticides across veterinary hospitals, animal farms, and home-care settings. 

Download Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00040100

Market Report Drivers

Rising Prevalence of Parasitic Infections

One of the major drivers of the veterinary parasiticides market is the continuing occurrence of parasitic infections among companion animals and livestock. Internal and external parasites can affect animal health, productivity, growth, and overall well-being. Regular parasite-control programs therefore remain an important component of preventive veterinary care.

Veterinary parasiticides help control parasites such as worms, ticks, fleas, mites, and other organisms that can negatively affect animals. Increased awareness among veterinarians, farmers, and pet owners regarding preventive treatment is supporting the use of parasiticide products.

Growing Pet Ownership and Animal Healthcare Spending

The expansion of companion animal ownership is creating additional demand for veterinary healthcare products. Pet owners are increasingly willing to spend on preventive healthcare, routine veterinary consultations, and parasite-control treatments.

Dogs and cats represent important animal categories within the market, while horses and other companion or recreational animals also contribute to demand. The availability of convenient oral, topical, and other formulations is making regular parasite prevention easier for pet owners.

Expansion of the Livestock Industry

The expansion of livestock production is another important factor supporting demand for veterinary parasiticides. Cattle, pigs, horses, poultry, goats, and other production animals can be affected by parasites that may reduce productivity and compromise animal health.

Effective parasite management is therefore important for livestock producers seeking to maintain animal productivity and reduce health-related losses. The livestock animal parasiticides market is also expected to expand, with The Insight Partners projecting the segment to reach US$21.36 billion by 2034 from US$13.85 billion in 2025. (The Insight Partners)

Increasing Focus on Preventive Animal Healthcare

Veterinary healthcare is increasingly shifting toward prevention rather than treatment after disease develops. Regular parasite control can form part of preventive healthcare programs recommended by veterinarians.

This trend is particularly relevant to companion animals, where owners increasingly seek routine protection against fleas, ticks, intestinal worms, and other parasites. In livestock production, preventive parasite management can also support animal health and productivity.

Product Innovation and Formulation Development

Product innovation is playing an important role in the evolution of the veterinary parasiticides market. Manufacturers are developing products designed to provide broader parasite coverage, improved convenience, and more targeted treatment options.

The market is segmented into ectoparasiticides, endoparasiticides, and endectocides. Ectoparasiticides are used against external parasites, while endoparasiticides target internal parasites. Endectocides can provide activity against both internal and external parasites.

Manufacturers are also focusing on different routes and formulations to improve treatment convenience. Innovations in oral, topical, injectable, and other delivery approaches can help address the varying needs of veterinarians, pet owners, and livestock producers.

Expansion of Veterinary Healthcare Infrastructure

The expansion of veterinary hospitals, clinics, animal farms, and home-based animal care is improving access to parasite-control products. The Insight Partners segments the global market by end user into veterinary hospitals, animal farms, and home-care settings. 

Growing veterinary awareness and improving access to animal healthcare services can encourage more regular parasite screening and preventive treatment. Distribution through veterinary channels and retail networks is also helping manufacturers reach a wider customer base.

Top Players in the Veterinary Parasiticides Market

The veterinary parasiticides market includes several major animal-health companies competing through product development, research and development, geographic expansion, partnerships, and portfolio diversification.

Key companies active in the broader animal parasiticides industry include

• Bayer Animal Health

• Merck Animal Health

• Zoetis

• Boehringer Ingelheim

• Elanco Animal Health

• Virbac

• Ceva Santé Animale

• Dechra Pharmaceuticals

• Vetoquinol

• Animalcare Group

Competition is influenced by product efficacy, safety, formulation convenience, brand recognition, regulatory approvals, distribution networks, and the ability to address parasite resistance and evolving veterinary requirements.

Market Segmentation

Based on type, the global veterinary parasiticides market is divided into:

• Ectoparasiticides

• Endoparasiticides

• Endectocides

Based on animal type, the market is segmented into:

• Dogs

• Cats

• Horses

• Cattle

• Pigs

• Poultry

• Goats

Based on end user, the market is categorized into:

• Veterinary Hospitals

• Animal Farms

• Home Care Settings

The global market analysis covers North America, Europe, Asia Pacific, South and Central America, and the Middle East and Africa, with country-level analysis included within the regional assessment. 

Regional Market Outlook

North America, Europe, Asia Pacific, South and Central America, and the Middle East and Africa represent the major geographic markets for veterinary parasiticides. Demand varies across regions according to pet ownership, livestock populations, veterinary infrastructure, parasite prevalence, animal-health expenditure, and regulatory requirements.

The United States represents an important market, with demand supported by factors including rising incidence of parasitic infections, growing pet ownership, expansion of the livestock industry, and evolving animal-health practices. 

Asia Pacific also presents opportunities associated with expanding livestock production, increasing awareness of animal healthcare, developing veterinary infrastructure, and rising companion-animal ownership.

Future Outlook

The future of the veterinary parasiticides market is expected to be shaped by increasing emphasis on preventive animal healthcare, product innovation, expanding pet ownership, and continued growth in livestock production.

Manufacturers are likely to focus on broad-spectrum parasite control, convenient dosage forms, improved treatment compliance, targeted formulations, and products designed to address parasite resistance. Research and development investments may also support the development of new active ingredients and improved delivery technologies.

The increasing integration of companion-animal healthcare with digital veterinary services and online purchasing channels could further improve consumer access to parasite-control products. Meanwhile, livestock producers are expected to continue emphasizing effective parasite management as part of animal health, productivity, and farm-management programs.

Overall, increasing awareness of animal health and preventive care is expected to sustain demand for veterinary parasiticides through the forecast period. The Insight Partners estimates that the market could reach US$21.52 billion by 2034, representing substantial expansion from its 2025 value of US$11.35 billion.

Related Reports

Creatinine Measurement Market Demand, Share & Growth by 2034

Cell Expansion Market Size, Share & Growth Forecast Report 2031

About US

The Insight Partners provides comprehensive syndicated and tailored market research services across the healthcare, technology, and industrial sectors. The company delivers market intelligence and strategic insights to help organizations understand emerging trends, identify growth opportunities, and make informed business decisions in rapidly evolving markets.

Contact Us

Contact Person: Ankit Mathur
E-mail:[email protected]
Phone: +1-646-491-9876